# q01 rev 2 - independent review (fresh question-review), 2026-10-06

Raw return as received:

q01 is ready on local checks only, with marginal suitability for the Medium target. "Flat" is the only defensible answer, both blind solvers matched, the closed-book solver missed and the shortcut audit is clear. Easy is the most likely single platform outcome, and no platform run exists yet, so status stays `checked`.

**q01 (rev 2; tested_sha256: f103b326cdd8df6d9676a1e742d3af3146ddb82878a88e29225208cfa5deaee1)**

**gold_verified: yes.** I rebuilt "Flat" from the originals.
- **The event:** Doc 6 (D05) l.81 lists "U.S. Consulting Services (which was divested in April 2026)" among the businesses "grouped together in Other". l.95 says Q3 FY2026 sales fell "due to the April 2026 divestiture". l.269 and l.393 repeat the date, all from the same document.
- **Other's FY2026 adjusted operating income guidance, by issue date:**
  - Doc 3, Nov 5, 2025: "1% to 4% decline" (D06 l.138)
  - Doc 4, Feb 4, 2026: "Flat" (D01 l.114; dateline l.17)
  - Doc 5, May 6, 2026: "High-single digit growth" (D03 l.123)
  - Doc 6, Aug 5, 2026: "~10% growth" (D05 l.118)
- **Date check (script):** all 30 April 2026 days fall inside fiscal 2026 (Oct 1, 2025 to Sep 30, 2026). Every one falls under the Feb 4 edition: 56 or more days after it and at least 6 days before May 6.
- **No update between Feb 4 and the closing:** Doc 5 l.17 says the "previous range" was "$17.45 to $17.75", which is Doc 4's range. Its narrowed interest expense and share count also start from Doc 4 (l.112), and l.112 ties the Other change to MWI's held-for-sale status. Doc 6's "$17.70 to $17.90" mismatch only concerns May to August.
- **Premise check:** "closed the divestiture ... during fiscal 2026" asserts nothing unsupported. It is the ordinary meaning of "was divested", and l.95 shows the effect inside Q3 FY2026.
- **The group fits only Other:**
  - From Q1 FY2026 the U.S. segment is U.S. Human Health "(excluding legacy U.S. Consulting Services)" (D06 l.121).
  - International holds Alliance, Innomar, World Courier and the strategic PharmaLex components.
  - The wording rules out the consolidated 11.5% to 13.5%, the Other revenue row (1% to 5%) and the FY2025 U.S.-segment reading. "Then" is what excludes the U.S. segment, so it should stay.
- **Equivalent answers:** flat, no growth, 0%.

**outcome: A: match; B: match.**
- Both packets are fresh, their text hashes equal the snapshot, and they carry the verbatim question.
- Both answered "Flat" with high confidence from Doc 6 plus Doc 4.
- Both rejected May 6, Aug 5 and the U.S.-segment 14% to 16%; B also rejected the revenue row.
- B saw question.txt in a directory listing only. That is not contamination.

**closed-book: misses.** It answered "8% to 10% ... U.S. Healthcare Solutions" at low confidence, which is not equivalent to Flat. It recalled only the November 2025 EPS range ($17.45 to $17.75) and never mentioned Other. This is the fourth local closed-book miss.

**necessity:**
- **Doc 6 (D05)** is the only source that dates the closing.
  - "April" occurs in no other document. Docs 4 and 5 say only "held for sale".
  - Doc 5 (May 6) still lists the unit in Other without any closing note, and no document gives an expected closing date.
  - Without Doc 6, the rev 2 probe (ids renumbered, neutral folder name) forced "High-single digit growth" at p 0.5, with Flat at 0.3. That is off the gold.
- **Doc 4 (D01)** is the only FY2026 source of "Flat".
  - The other "flat" and "no growth" hits are FY2025 International lines (D02 l.113 and l.115, D04 l.117).
  - Doc 5 says only that Other's expectations were "updated", without the prior value.
  - Without Doc 4, the probe answered "1% to 4% decline" at p 0.6, off the gold.
- **Unlisted documents:** Doc 5 (support and decoy) and Doc 3 (superseded edition; the composition is repeated in Docs 4 to 6) are replaceable. Docs 1 and 2 contain no "2026".
- {Doc 4, Doc 6} is the only minimal set.

**shortcut: clear.**
- The shortest route is Doc 6 l.81, then the edition datelines (Doc 4 l.17, Doc 5 l.15, Doc 6 l.15), then Doc 4 l.114.
- No passage pairs the event with "Flat", and no later edition restates the February value.
- The bundle overview (capture l.65-70) shows "April 2026" only as a bare date and gives no Other outlook.
- The audit's route and its rejected answers match my checks. Its risk note stands: this is a two-document date match, and only the edition trap defends it.

**source_assessment: no known gaps.**
- intake.json shows all six documents matching the capture with zero gap characters, and the report lists no source gaps.
- I recomputed the corpus hashes and they equal the snapshot.
- The guidance tables' bold "update" markers don't survive in the text. That is lost formatting, not a missing range. The premises come from prose, the gold is cell text, there are no exclusions, dates settle uniqueness, and neither necessity nor the shortcut depends on bold.

**difficulty: medium (marginal).** This is local suitability only.
- **Pushes it harder:**
  - It is the same untied mechanism as aq-00964 q01 (Medium) and aq-00745 q09 (High). Local reviews underestimated both.
  - The event sits only in the latest release, beside that release's own later "~10% growth".
  - A second post-event decoy with the same row label (May 6) has a quarter that ended before the closing.
  - The edition in force is two editions back, in the middle of the series rather than at either end.
- **Pulls it easier:**
  - The month is printed plainly and a search for "divest" finds it.
  - Two timing cues ("At the time of the closing", "then included") may weaken the trap slightly compared with rev 1.
  - The answer is a printed label with no arithmetic.
  - Every edition is dated in its file name and dateline.

Platform estimate:

| Outcome | Rough probability |
| --- | --- |
| Too easy | ~12% |
| Easy | ~35% |
| Medium | ~28% |
| High | ~12% |
| Too hard | ~5% |
| An unseen ladder result (for example Low 0/5, then Medium 4–5/5) | ~8% |

Medium or better is about 40–50%.

Document-check risk:
- Doc 6: a "may not be needed" flag is about 20–25% likely. The probe put Flat at 0.3, and how the platform scores a split between its two attempts is unknown.
- Doc 4: about 5%. It would take an interpolation guess to land on "Flat".

Other platform risks: the low model reaching Flat closed-book, about 5%; the Original question check, about 5%.

**verdict: ready**

**findings:**
1. **Q1–Q12, Q14 pass locally.**
   - Q10: 41 words, inside the 20–45 aim with no 60-word warning, one ask.
   - Rule 10: the answer is a fact about the company, not about the documents.
   - Q11: each wrong edition gives a different same-label answer, so the edition lever is active.
   - Q13: platform result pending; status stays `checked`.
2. **Original question:** rev 2 is no longer a near copy of aq-00964 q01.
   - Token-sequence similarity is 0.17 (rev 1 was 0.44). The only shared word pair is "of its", and there is no shared three-word run.
   - The mechanism and the final-clause shape ("the group/segment that [then] included ...") still echo it.
   - The platform check has not been seen, so this stays unknown.
3. **Verbatim evidence (blocking on the form, unknown):** "Other(2)|Flat|$352M" is the only possible quote for c1.
   - The capture (l.2489) shows the same piped row, which helps, but the form's check is still unconfirmed.
   - Use Save passage on Doc 4's row before submitting. Any change to the evidence means a new revision and fresh checks.
4. **Reasoning-number rule (my emulation, unconfirmed on the form):** every number is in the document its step names.
   - Doc 6 holds "April 2026", "August 5, 2026" and "~10%"; Doc 5 holds "May 6, 2026" and "$17.45 to $17.75"; Doc 4 holds "February 4, 2026".
   - The uncited conclusion repeats only "2026", and there are no computed values.
   - The reasoning cites Doc 5 without listing or quoting it. If the form's "Derive the rest" proposes marking it necessary, decline.
5. **Doc 6 removal residual:** this is inherent to the design and needs no change unless the platform flags it. If it does, the 200-character reviewer note can say Doc 6 is the only document that dates the closing.
6. **Records:** the report's recomputed fingerprint equals the snapshot and every rev 2 record (A, B, closed-book, audit). The probes were built correctly and used the verbatim rev 2 question. Rev 0 and rev 1 records are history and don't count.
7. **Set:** no shared answer path and no mutual giveaways with q02 or q03. q01 is the bundle's only edition trap.
8. **Authorship:** origin is claude, but the export takes only user and the "I wrote this question myself" box cannot be ticked truthfully. That decision is yours.
